Cargando…

Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling

Despite the clinical benefits of androgen deprivation therapy, most patients with advanced androgen‐dependent prostate cancer (ADPC) eventually relapse and progress to lethal androgen‐independent prostate cancer (AIPC), also termed castration‐resistant prostate cancer (CRPC). MiRNAs can be packaged...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Weixi, Kong, Piaoping, Feng, Kangle, Liu, Chunhua, Gong, Xubo, Sun, Tao, Duan, Xiuzhi, Sang, Yiwen, Jiang, Yu, Li, Xiang, Zhang, Lingyu, Tao, Zhihua, Liu, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637070/ https://www.ncbi.nlm.nih.gov/pubmed/37671589 http://dx.doi.org/10.1111/cas.15948

Ejemplares similares

Emerging proteins involved in castration-resistant prostate cancer via the AR-dependent and AR-independent pathways (Review)
por: Feng, Kangle, et al.
Publicado: (2023)

New insights into lipid metabolism and prostate cancer (Review)
por: Zhang, Zhengliang, et al.
Publicado: (2023)

Emerging Proteins in CRPC: Functional Roles and Clinical Implications
por: Kong, Piaoping, et al.
Publicado: (2022)

Emerging roles and mechanisms of microRNA-222-3p in human cancer (Review)
por: Wang, Danhua, et al.
Publicado: (2021)

SGK1 in Human Cancer: Emerging Roles and Mechanisms
por: Sang, Yiwen, et al.
Publicado: (2021)

The MYH9 Cytoskeletal Protein Is a Novel Corepressor of Androgen Receptors
por: Liu, Chunhua, et al.
Publicado: (2021)

SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway
por: Liu, Weiwei, et al.
Publicado: (2017)

Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
por: Gong, Xubo, et al.
Publicado: (2022)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Circulating tumor cells in prostate cancer: Precision diagnosis and therapy
por: Liu, Weiwei, et al.
Publicado: (2017)

Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
por: Huang, Yujie, et al.
Publicado: (2022)

Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase
por: Yu, Pan, et al.
Publicado: (2017)

Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients
por: Sun, Tao, et al.
Publicado: (2019)

Autophagy regulates the degeneration of the auditory cortex through the AMPK-mTOR-ULK1 signaling pathway
por: Yuan, Jie, et al.
Publicado: (2018)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

Targeting ganglioneuromas with mTOR inhibitors
por: Tao, Ting, et al.
Publicado: (2021)

Identification and Validation of Three Hub Genes Involved in Cell Proliferation and Prognosis of Castration-Resistant Prostate Cancer
por: Yu, Pan, et al.
Publicado: (2022)

The clinicopathological and prognostic significance of mTOR and p-mTOR expression in patients with non-small cell lung cancer: A meta-analysis
por: Qiu, Weiwei, et al.
Publicado: (2022)

mTOR regulates GPVI-mediated platelet activation
por: Wang, Longsheng, et al.
Publicado: (2021)

Rapid and sensitive detection of L‐FABP for prediction and diagnosis of acute kidney injury in critically ill patients by chemiluminescent immunoassay
por: Sun, Tao, et al.
Publicado: (2021)

The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy
por: Duan, Xiuzhi, et al.
Publicado: (2019)

Targeting mTOR for cancer therapy
por: Hua, Hui, et al.
Publicado: (2019)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Astrocyte-derived exosomal nicotinamide phosphoribosyltransferase (Nampt) ameliorates ischemic stroke injury by targeting AMPK/mTOR signaling to induce autophagy
por: Deng, Yang, et al.
Publicado: (2022)

Trifolirhizin induces autophagy-dependent apoptosis in colon cancer via AMPK/mTOR signaling
por: Sun, Dongdong, et al.
Publicado: (2020)

PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer
por: Yasumizu, Yota, et al.
Publicado: (2018)

Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
por: Guo, Mengnan, et al.
Publicado: (2021)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

L-Theanine Regulates the Abundance of Amino Acid Transporters in Mice Duodenum and Jejunum via the mTOR Signaling Pathway
por: Liu, Kehong, et al.
Publicado: (2022)

Autophagy termination and lysosome reformation regulated by mTOR
por: Yu, Li, et al.
Publicado: (2010)

Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2020)

Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer
por: Sun, Tong, et al.
Publicado: (2018)

The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
por: Iranpanah, Amin, et al.
Publicado: (2023)

Control of mTOR Signaling by Ubiquitin
por: Jiang, Yao, et al.
Publicado: (2019)

Alpha‐lipoic acid inhibits lung cancer growth via mTOR‐mediated autophagy inhibition
por: Peng, Peipei, et al.
Publicado: (2020)

How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
por: Duan, Xiuzhi, et al.
Publicado: (2023)

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer
por: Gui, Bin, et al.
Publicado: (2017)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dq3sja931fd45r60bgbumljsfv